Gislane Lelis Vilela de Oliveira
Overview
Explore the profile of Gislane Lelis Vilela de Oliveira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
520
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khan A, Busselberg D, de Oliveira G, Khan S
Front Mol Biosci
. 2023 Aug;
10:1249301.
PMID: 37533678
No abstract available.
2.
Pucca M, Villena J, de Oliveira G
Front Nutr
. 2023 Jul;
10:1233863.
PMID: 37426185
No abstract available.
3.
Borgonovi T, Salgaco M, de Oliveira G, de Carvalho L, Pinheiro D, Todorov S, et al.
Foods
. 2022 Dec;
11(24).
PMID: 36553855
The effect of putative probiotic fermented milk (FM) with buriti pulp (FMB) or passion fruit pulp (FMPF) or without fruit pulp (FMC) on the microbiota of healthy humans was evaluated....
4.
Pereira M, Levy M, Nissapatorn V, de Oliveira G
Front Cell Infect Microbiol
. 2022 Oct;
12:1054190.
PMID: 36304933
No abstract available.
5.
Ferreira-Junior A, Borgonovi T, de Salis L, Leite A, Dantas A, De Salis G, et al.
Int J Environ Res Public Health
. 2022 Aug;
19(16).
PMID: 36011823
The intestinal microbiota plays an important role in the immune response against viral infections, modulating both innate and adaptive immune responses. The cytokine storm is associated with COVID-19 severity, and...
6.
de Oliveira G, de Barros Cardoso C, Taneja V, Fasano A
Front Immunol
. 2021 Aug;
12:727485.
PMID: 34394133
No abstract available.
7.
Lemos M, Zucoloto T, Oliveira M, de Oliveira G
J Clin Rheumatol
. 2021 May;
28(2):e568-e573.
PMID: 34030162
Gastrointestinal (GI) involvement is an early manifestation in systemic sclerosis (SSc), affecting more than 90% of patients, and severe GI disease is a marker of poor prognosis and mortality. Recent...
8.
Pellizoni F, Leite A, Rodrigues N, Ubaiz M, Gonzaga M, Takaoka N, et al.
Int J Environ Res Public Health
. 2021 Apr;
18(9).
PMID: 33925359
Dysbiosis, associated with barrier disruption and altered gut-brain communications, has been associated with multiple sclerosis (MS). In this study, we evaluated the gut microbiota in relapsing-remitting patients (RRMS) receiving disease-modifying...
9.
Cayres L, de Salis L, Rodrigues G, van Helvoort Lengert A, Biondi A, Sargentini L, et al.
Front Immunol
. 2021 Mar;
12:579140.
PMID: 33746942
Hashimoto thyroiditis (HT) is the most common autoimmune disease worldwide, characterized by chronic inflammation and circulating autoantibodies against thyroid peroxidase and thyroglobulin. Patients require hormone replacement with oral levothyroxine, and...
10.
de Oliveira G, Oliveira C, Pinzan C, de Salis L, de Barros Cardoso C
Front Immunol
. 2021 Mar;
12:635471.
PMID: 33717181
COVID-19 is an infectious disease caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), and according to the World Health Organization (WHO), to date, SARS-CoV-2 has already infected more than...